Drug Product
Company Overview
About
Gehrlicher GmbH is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Germany
Founded:1992
Employees:2,558
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Europe
Regulatory Approvals
Drug Approval JJSAE7
EMA · #APR-T462DR92 · 2022-09-01
Drug Approval 552UCT
EMA · #APR-TVDXMV6X · 2018-12-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-P8GPHY7J
Issued: 2020-10-05
Expires: 2025-09-13
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-KEXNO9B3
Issued: 2020-04-27
Expires: 2025-01-18
Health Canada GMP
Health Canada
Cert #: CERT-P4XGQC0N
Issued: 2020-05-02
Expires: 2025-06-13
Loading CDMO intelligence...
Key facts about Gehrlicher GmbH
- Gehrlicher GmbH is headquartered in Germany.
- Gehrlicher GmbH was founded in 1992.
- Gehrlicher GmbH has 2,558 employees.
- Gehrlicher GmbH's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Gehrlicher GmbH
Directory pages this company appears in, each with the full list of matching manufacturers.